Brief: Vicore Provides An Update On The Attract-3 Covid-19 Trial

Vicore Pharma Holding AB

15/09/2022 18:23

Sept 15 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * VICORE PROVIDES AN UPDATE ON THE ATTRACT-3 COVID-19 TRIAL
    * ATTRACT-3 DID NOT MEET ITS PRIMARY ENDPOINT, REDUCTION OF
ALL-CAUSE MORTALITY AT 60 DAYS
    * LACK OF EFFECT EXPLAINED BY NEW VIRUS MUTATIONS
    * COMPANY WILL FOCUS DEVELOPMENT OF C21 FOR TREATMENT OF IPF
AND
PAH

Source text for Eikon:  ID:nWkrbYQbsD 
Further company coverage:  VICOR.ST 

 ((Reuters.Briefs@thomsonreuters.com;))